Get started
RepliCel Life Sciences Inc.RepliCel Life Sciences Inc.RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

REPCF chart


Full chart

REPCF upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪501.08 K‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
0.3221
Basic EPS (TTM)
0.0165 USD
Net income (FY)
‪−235.20 K‬ USD
Revenue (FY)
‪266.89 K‬ USD
Shares float
‪36.89 M‬
Beta (1Y)
2.14

About REPLICEL LIFE SCIENCES INC


Sector
Health Technology
CEO
Andrew Schutte
Headquarters
Vancouver
Website
replicel.com
Founded
1967
FIGI
BBG000PMW6N9
RepliCel Life Sciences, Inc. is a regenerative medicine company, which engages in developing cell therapies for aesthetic and orthopedic conditions. Its products include RCH-01, RCS-01, RCT-01, and DermaPrecise. The company was founded by Kevin McElwee and Rolf Hoffmann on April 24, 1967 and is headquartered in Vancouver, Canada.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

REPCF news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of REPCF is 0.0010 USD — it has decreased by −80.00% in the past 24 hours. Watch RepliCel Life Sciences Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RepliCel Life Sciences Inc. stocks are traded under the ticker REPCF.
REPCF stock has fallen by −75.00% compared to the previous week, the month change is a 400.00% rise, over the last year RepliCel Life Sciences Inc. has showed a −97.92% decrease.
REPCF reached its all-time high on Aug 3, 2004 with the price of 339.0000 USD, and its all-time low was 0.000001 USD and was reached on Nov 1, 2024. View more price dynamics on REPCF chart.
See other stocks reaching their highest and lowest prices.
REPCF stock is 400.00% volatile and has beta coefficient of 2.14. Track RepliCel Life Sciences Inc. stock price on the chart and check out the list of the most volatile stocks — is RepliCel Life Sciences Inc. there?
Today RepliCel Life Sciences Inc. has the market capitalization of ‪501.08 K‬, it has decreased by −0.42% over the last week.
Yes, you can track RepliCel Life Sciences Inc. financials in yearly and quarterly reports right on TradingView.
RepliCel Life Sciences Inc. is going to release the next earnings report on May 6, 2025. Keep track of upcoming events with our Earnings Calendar.
REPCF net income for the last quarter is ‪−159.80 K‬ USD, while the quarter before that showed ‪−137.33 K‬ USD of net income which accounts for −16.36% change. Track more RepliCel Life Sciences Inc. financial stats to get the full picture.
No, REPCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RepliCel Life Sciences Inc. EBITDA is ‪−423.73 K‬ USD, and current EBITDA margin is −391.47%. See more stats in RepliCel Life Sciences Inc. financial statements.
Like other stocks, REPCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RepliCel Life Sciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RepliCel Life Sciences Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RepliCel Life Sciences Inc. stock shows the sell signal. See more of RepliCel Life Sciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.